Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Nature Communications
|
January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes
Maria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.
Oncotarget
|
October 14, 2015
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
Nidhi Bansal, Kevin Petrie, Rossitza Christova, et al.
Scientific Reports
|
July 21, 2022
PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
Xia Ding, Zhou Zhu, John Lapek, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2025
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus formation
Katherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.
Cell Reports
|
August 9, 2018
Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development
Rajshekhar R Giraddi, Chi-Yeh Chung, Richard E Heinz, et al.
Molecular Cell
|
June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma
Chiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 31, 2026
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus organization
Katherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.
Communications Biology
|
February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
Wazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Gastroenterology
|
July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D<sub>2</sub>
Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.
Molecular Cancer Therapeutics
|
November 5, 2021
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
Kristen Jensen-Pergakes, John Tatlock, Karen A Maegley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Nature Communications
|
January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes
Maria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.
Oncotarget
|
October 14, 2015
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
Nidhi Bansal, Kevin Petrie, Rossitza Christova, et al.
Scientific Reports
|
July 21, 2022
PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
Xia Ding, Zhou Zhu, John Lapek, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2025
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus formation
Katherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.
Cell Reports
|
August 9, 2018
Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development
Rajshekhar R Giraddi, Chi-Yeh Chung, Richard E Heinz, et al.
Molecular Cell
|
June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma
Chiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 31, 2026
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus organization
Katherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.
Communications Biology
|
February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
Wazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Gastroenterology
|
July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D<sub>2</sub>
Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.
Molecular Cancer Therapeutics
|
November 5, 2021
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
Kristen Jensen-Pergakes, John Tatlock, Karen A Maegley, et al.
Page
of 3